CD8A and non-small cell lung carcinoma: Given that type I IFN signalling induces CD8+ T‐cell responses against tumours,31 and that cGAS/STING signalling pathway promotes type I IFN production and adaptive immunity,32 the expression of cGAS/STING, IFN‐b and downstream chemokines were detected in NSCLC cells.